Litigation Details for Celgene Corporation v. Aurobindo Pharma Limited (D. Del. 2018)

✉ Email this page to a colleague

Docket	⤷ Sign Up	Date Filed	2018-07-06
Court	District Court, D. Delaware	Date Terminated	2018-10-04
Cause	35:271 Patent Infringement	Assigned To	Richard Gibson Andrews
Jury Demand	None	Referred To
Parties	AUROBINDO PHARMA U.S.A., INC.
Patents	6,962,940; 7,208,516; 7,427,638; 7,659,302; 7,893,101; 8,455,536; 8,802,717; 9,018,243; 9,872,854
Attorneys	Jack B. Blumenfeld
Firms	Morris, Nichols, Arsht & Tunnell
Link to Docket	External link to docket

The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2018-07-06	1	Complaint	United States Patent Nos. 6,962,940 (“the ’940 Patent”), 7,208,516 (“the ’516 Patent”), 7,427,638 (… (“the ’638 Patent”), 7,659,302 (“the ’302 Patent”), 7,893,101 (“the ’101 Patent”), 8,455,536 (“the ’… ’536 Patent”), 8,802,717 (“the ’717 Patent”), 9,018,243 (“the ’243 Patent”), and 9,872,854 (“the ’854… This is a civil action for patent infringement arising under the patent laws of the United States, …854 Patent”) (collectively, “the Patents-in-Suit”). Case 1:18-cv-01005-RGA Document 1 Filed 07/06/18	External link to document
2018-10-05	7		the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,962,940 B2; 7,208,516 B2; 7,427,638…2018 4 October 2018 1:18-cv-01005 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document